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Abstract 
Background  
Anticancer drugs are aimed primarily at inhibiting the growth and proliferation of cancer cells. Srikaya leaves 
(Annona squamosa L.) had been proven to possess various therapeutic effects and potential to be developed as 
anticancer drugs due to its cytotoxic activity. 
Objective 
This study aimed to assess the anticancer activity of srikaya leaves (Annona squamosa L.) fraction. 
Methods  
Methanol fraction of srikaya leaves were obtained at concentrations of 500; 250; 125; 62.5; 31.25 µg/ml. 
Srikaya methanol fraction and cisplatin as control were given to a plate that was sealed with T47D cells for MTT 
assay. Identification of compounds in the methanol fraction of srikaya leaves was performed with thin layer 
chromatography (TLC). Data were collected in the form of absorbance value and half-maximal inhibitory 
concentration (IC50) value was determined by linear regression. Data analysis was carried out with paired T test, 
unpaired T test, and ANOVA. 
Results 
Average percentage of T47D cells viability increased with the decrease in the concentration of srikaya 
methanol fraction. Obtained IC50 value was 174.25 µg/ml which was quite active and potential to be developed as an 
anticancer drug. Methanol fraction of srikaya leaves contained secondary terpenoid metabolites, steroids, phenols, 
flavonoids, alkaloids and tannins. Flavonoid was the dominant metabolites in phytochemical tests and believed to play 
a major role in cytotoxic activity of srikaya leaves. 
Conclusion 
Methanol fraction of srikaya leaves possessed the cytotoxic effect on T47D cancer cell line through the role 
of flavonoid metabolites. 
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Introduction 
Cancer is of the many diseases prominent as the leading cause of burden and mortality in 
the world. According to World Health Organization (WHO) in 2018, the global cancer burden is 
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estimated to have risen to 18.1 million new cases and 9.6 million deaths. The morbidity is one in 
5 men and one in 6 women, with a mortality of one in 8 men and one in 11 women. Worldwide, 
the 5-year prevalence or total survivor within 5 years is estimated to be 43.8 million [1]. 
Anticancer drugs are aimed primarily at inhibiting the growth and proliferation of cancer 
cells. Molecular targets for anticancer drugs in breast cancer cells include estrogen receptor (ER), 
human epidermal growth factor receptor 2 (HER2), and vascular endothelial growth factor 
(VEGF). The target for induction of apoptosis and anti-apoptotic inhibition involves the p53-
mitochondrial and TNF-related apoptosis-inducing ligand (TRAIL) receptors, nuclear 2 
transcription factors, cell cycle processes, signal transduction and angiogenesis [2]. 
Srikaya (Annona squamosa L.) had been proven to possess various therapeutic effects [3-8] 
and potential to be developed as anticancer drugs [9]. This plant contains several active 
compounds including flavonoids, borneol, camphor, alkaloids, terpenes, saponins, tannins, 
polyphenols and polyketide compounds [10]. Some previous studies had shown that srikaya plants 
possessed potential cytotoxic activity [11]. This study was conducted to complement previous 
research and was carried out only at the cytotoxic test stage. This study was conducted to assess 
the efficacy of the polar fraction of srikaya leaves (Annona squamosa L.) on cytotoxic activity 
against T47D cells. 
 
Methods 
This study was an experimental in vitro study using the T47D breast cancer cell line. Srikaya 
leaves were obtained from the Traditional Medicine Research and Development Center, 
Tawangmangu, Indonesia. Simplicia of the srikaya leaves were first dried and mashed, then 
extracted with methanol solvent by maceration for 3x24 hours. Simplicia filtration and pulp 
maceration were performed. Macerate was evaporated with a rotary evaporator to obtain the thick 
extracts. The obtained extract was added by aquadest in 1:1 ratio. N-hexane solvent as much as 
200 ml (5x200ml) was added and then separated with a separating funnel. Ethyl acetate solvent as 
much as 200 ml (5x200 ml) was added. The n-hexane, ethyl acetate and methanol fractions were 
obtained. In this study, the test fraction to be explored was methanol. 
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Methanol fraction from srikaya leaves was diluted with dimethyl sulfoxide (DMSO) and 
Dulbecco's modified Eagle’s medium (DMEM) to obtain concentrations of 500; 250; 125; 62.5; 
and 31.25 µg/ml. Cisplatin was used with a concentration of 50: 25: 12,5: 6,25: 3,125 µg/ml. 
Furthermore, the test fraction and cisplatin were given to a plate that was sealed with T47D cells 
for the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Identification 
of compounds found in the methanol fraction of srikaya leaves was performed with thin layer 
chromatography (TLC). 
Data were collected in the form of absorbance from enzyme-linked immunosorbent assay 
(ELISA) reader. From the absorbance values, cytotoxic activity of the test compounds was 
expressed by half-maximal inhibitory concentration (IC50) values which was determined with 
linear regression. The IC50 value indicated the concentration value which results in 50% inhibition 
of cell proliferation. The cytotoxic activity against cancer cells was classified as “very active” if 
the IC50 value was <10 µg/ml, “active” if the IC50 value was 10-100 µg/ml and “quite active” if 
the IC50 value was 100-500 µg/ml [12]. Data analysis was carried out with paired T test, unpaired 
T test, and ANOVA. 
 
Results 
Table 1. Efficacy of Srikaya Leaves Fraction against Cancer Cell Line Viability 
No Treatment 
Cell Line Viability (%) 
Mean ± SD 
1 MF 500 46.78±0,014* 
2 MF 250 49.89±0,016* 
3 MF 125 59.84±0,007* 
4 MF 62.5 62.97±0,029* 
5 MF 31.25 65.79±0,021* 
6 CIS 50 23.60±0,070 
7 CIS 25 38.13±0,021 
8 CIS 12.5 56.10±0,032 
9 CIS 6.25 61.60±0,070 
10 CIS 3.125 63.19±0,035 
MF: Methanol fraction; CIS: Cisplatin; * p< 0,05 vs Cis 3,125 posthoc test 
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As shown in Table 1, methanol fraction of srikaya leaves affected the viability of cancer 
cells. The highest concentration of 500 µg/ml resulted an average viability of 46.77% and the 
average percentage of viability increased with a decrease in the concentration of the test fraction 
at a concentration of 250 µg/ml (49.89%), 125 µg/ml (59.84%), 62.25 µg/ml (62.97%), 31.25 
µg/ml (65.79%), respectively. The obtained IC50 value was 174.25 µg/ml. Based on the 
classification, the IC50 value of methanol fraction of srikaya leaves was quite active and potential 
to be developed as an anticancer drug. 
As exhibited in Table 2, the methanol fraction of srikaya leaves contained secondary 
terpenoid metabolites, steroids, phenols, flavonoids, alkaloids and tannins. Flavonoid was the 
dominant metabolites in phytochemical tests and believed to play a major role in cytotoxic activity 
of srikaya leaves. 
Tabel 2. Phytochemical Analysis of Srikaya 
Fraction Spot Colors Metabolite 
Methanol Fraction Purple, yellow, dark 
yellow and brown 
Terpenoid, steroid, phenol 
flavonoid, alkaloid and tannin 
 
Discussion 
Flavonoid compounds are known to possess the ability to induce apoptosis. Apoptosis as 
the programmed cell death plays an important role in the process of cancer regulation. The 
mechanism of flavonoid in inducing apoptosis is through the inhibition of DNA topoisomerase I/II 
activity, modulation of signaling pathways, decreased expression of Bcl-2 and Bcl-XL genes, 
increased expression of Bax, Bak and p53 genes, and activation of endonuclease [13, 14]. 
Flavonoids were the main compounds capable of spurring apoptosis with a variety of mechanisms 
in the methanol extract of kenikir leaves (Cosmos caudatus Kunth) which had cytotoxic properties 
against T47D cells with IC50 of 344.91 µg/ml. A study showed apoptotic death of myeloma cancer 
cells due to the influence of the chloroform fraction of papaya leaves (Carica papaya L.) with the 
main content of alkaloids allegedly through the initial stages of inhibiting the enzyme of DNA 
Topoisomerase II. With the inhibition of DNA topoisomerase enzyme activity, the process of the 
bonding between the enzyme and the DNA of the cancer cell was prolonged, protein linked DNA 
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breaks (PLDB) was formed, resulted in DNA fragmentation or damage to cancer cells and 
subsequently affected the cancer cell replication process [15-18]. 
  
Conclusion 
Methanol fraction of srikaya leaves possessed the cytotoxic effect on T47D cancer cell line 
through the role of flavonoid metabolites. 
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